Deutsche Bank Maintains Buy on HealthEquity, Raises Price Target to $71
Portfolio Pulse from jenniferd'souza@benzinga.com
Deutsche Bank analyst George Hill maintains a Buy rating on HealthEquity (NASDAQ:HQY) and raises the price target from $69 to $71.
June 07, 2023 | 3:03 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Deutsche Bank maintains a Buy rating on HealthEquity and raises the price target from $69 to $71.
The news of Deutsche Bank maintaining a Buy rating on HealthEquity and raising the price target from $69 to $71 is positive for the company. This indicates that the analyst has confidence in the company's growth potential and future performance. As a result, this news is likely to have a positive short-term impact on HealthEquity's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100